Literature DB >> 16211411

[Sleep-related breathing disorders. Sleep anamnesis questionnaire and determination of clinical results within the framework of staged diagnostics].

Y Fischer1, A Neagos, W Pirsig.   

Abstract

Sleep-related breathing disorders (SBAS) affect approximately 8% of the population of middle aged adults. At the age of 20 years, approximately 10% of the population snore, while at the age of 60 about 50% of men snore. Some 9% of middle aged women and 24% of middle aged men have an apnea hypopnea index (AHI) of >5 (number of nocturnal apnea and hypopnea per hour of sleep). Sleep apnea hypopnea syndrome is found in 2% of the women and 4% of the men, i.e. they have an AHI>5 associated with daytime sleepiness. Forms, check lists, summaries and patient-readable questionnaires have proved helpful in the evaluation of SBAS.

Entities:  

Mesh:

Year:  2005        PMID: 16211411     DOI: 10.1007/s00106-005-1314-2

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  53 in total

1.  Breathe Right nasal strips and the respiratory disturbance index in sleep related breathing disorders.

Authors:  J Gosepath; R G Amedee; S Romantschuck; W J Mann
Journal:  Am J Rhinol       Date:  1999 Sep-Oct

Review 2.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

3.  Axial configuration of the velopharyngeal valve and its valving mechanism.

Authors:  Y Finkelstein; M Shapiro-Feinberg; Y P Talmi; A Nachmani; A DeRowe; D Ophir
Journal:  Cleft Palate Craniofac J       Date:  1995-07

4.  Nasal surgery in the management of sleep apnea.

Authors:  V S Dayal; E A Phillipson
Journal:  Ann Otol Rhinol Laryngol       Date:  1985 Nov-Dec       Impact factor: 1.547

5.  An international study on sleep disorders in the general population: methodological aspects of the use of the Sleep-EVAL system.

Authors:  M M Ohayon; C Guilleminault; T Paiva; R G Priest; D M Rapoport; T Sagales; S Smirne; J Zulley
Journal:  Sleep       Date:  1997-12       Impact factor: 5.849

6.  [How frequent are pathologic ENT findings in patients with obstructive sleep apnea syndrome?].

Authors:  J Mayer-Brix; U Müller-Marschhausen; H Becker; J H Peter
Journal:  HNO       Date:  1989-12       Impact factor: 1.284

7.  A surgical treatment for snoring and obstructive sleep apnea.

Authors:  F B Simmons; C Guilleminault; L E Miles
Journal:  West J Med       Date:  1984-01

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Failure of tonsil and nose surgery in adults with long-standing severe sleep apnea syndrome.

Authors:  G Aubert-Tulkens; M Hamoir; J Van den Eeckhaut; D O Rodenstein
Journal:  Arch Intern Med       Date:  1989-09

10.  Effects of nasal surgery and tonsillectomy on sleep apnea.

Authors:  A H Rubin; I Eliaschar; Z Joachim; G Alroy; P Lavie
Journal:  Bull Eur Physiopathol Respir       Date:  1983 Nov-Dec
View more
  5 in total

1.  Current diagnostic trends in sleep disordered breathing.

Authors:  Joachim T Maurer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2006-10-05

2.  [Endoscopy in sleep medicine].

Authors:  J T Maurer; K Hörmann
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

Review 3.  [Update on upper airway evaluation in obstructive sleep apnea].

Authors:  J T Maurer; B A Stuck
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

Review 4.  The surgical treatment of sleep-related upper airway obstruction.

Authors:  Thomas Verse; Karl Hörmann
Journal:  Dtsch Arztebl Int       Date:  2011-04-01       Impact factor: 5.594

5.  [Anterior spondylosis of the cervical spine causing dyspnea and sleep disturbance].

Authors:  K Eysel-Gosepath; S Fürderer; K-S Delank; U Schröder; P Eysel
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.